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Summary
Antioxidants are protective molecules that neutralize reactive oxygen species and prevent
oxidative damage to cellular components such as membranes, proteins and nucleic acids,
therefore reducing the rate of cell death and hence the effects of ageing and ageing-related
diseases. The fortification of food with antioxidants represents an overlap between two diverse
environments, namely fortification of staple foods with essential nutrients that happen to have
antioxidant properties (e.g. vitamins C and E) and the fortification of luxury foods with health-
promoting but non-essential antioxidants such as flavonoids as part of the nutraceuticals/
functional foods industry. Although processed foods can be artificially fortified with vitamins,
minerals and nutraceuticals, a more sustainable approach is to introduce the traits for such
health-promoting compounds at source, an approach known as biofortification. Regardless of
the target compound, the same challenges arise when considering the biofortification of plants
with antioxidants, that is the need to modulate endogenous metabolic pathways to increase the
production of specific antioxidants without affecting plant growth and development and
without collateral effects on other metabolic pathways. These challenges become even more
intricate as we move from the engineering of individual pathways to several pathways
simultaneously. In this review, we consider the state of the art in antioxidant biofortification and
discuss the challenges that remain to be overcome in the development of nutritionally complete
and health-promoting functional foods.
Introduction
Fortification is the process of adding essential micronutrients and
other health-promoting compounds to foods. The fortification of
processed foods such as flour, bread, packaged cereals, dairy
products and salt is a public health policy in the industrialized
world, aiming to reduce the number of people suffering from
malnutrition and to increase general health and wellbeing in the
population. In developing countries, fortification programmes are
often unsustainable due to poor governance, inefficient food-
distribution networks and the prevalence of subsistence agricul-
ture in rural populations, which means that most agricultural
products are not processed centrally before distribution and
consumption. Approximately 50% of the global population is
thought to be malnourished but the vast majority of malnour-
ished people are the rural poor in developing countries, subsisting
on a diet of milled cereal grains lacking many essential nutrients
and other health-promoting compounds (Farre´ et al., 2011a,b;
Yuan et al., 2011). In these settings, biofortification is a more
sustainable strategy because this involves the fortification of crops
at source either through the application of nutrient-rich fertilizers
or the breeding or engineering of crops to synthesize and/or
accumulate nutritionally important compounds, therefore avoid-
ing the need to fortify processed food products (Go´mez-Galera
et al., 2010).
Biofortification programmes generally focus on essential
micronutrients, which are either organic compounds (vitamins)
or minerals required in amounts <1 mg/day. These compounds
act as cofactors or metabolic precursors and are required for
specific biological processes, such that insufficient intake results in
characteristic deficiency diseases (Zhu et al., 2007; Go´mez-Galera
et al., 2010; Table S1). The major deficiency diseases in devel-
oping countries correspond to essential nutrients that tend to be
present at low levels in milled cereal grains, for example vitamin
A, iron, iodine, zinc, vitamin C and folic acid. As well as their
requirement for particular metabolic processes, certain essential
nutrients also act as antioxidants or promote the activity or
availability of antioxidants, which help to prevent diseases that
result from or that are exacerbated by the accumulation of
oxidative damage to cells, including cancer, cardiovascular
disease and neurodegenerative disorders. Many non-essential
molecules consumed in the diet are also antioxidants with health-
promoting effects, and hence there is an overlap between
essential nutrients and non-essential compounds (sometimes
described as nutraceuticals) that act as antioxidants.
A key example of such a ‘dual-purpose nutrient’ is vitamin A,
which is obtained in the diet either as esters of retinol from meat
and dairy products or as pro-vitamin A carotenoids such as
b–carotene from plants. Vitamin A is converted into the visual
pigment rhodopsin (retinal), in the retina of the eye, and acts as a
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co-regulator of gene expression (retinoic acid); b-carotene is also
an antioxidant, as are many other (non-essential) carotenoids.
Similarly vitamin C (ascorbate) is an essential cofactor for several
enzymes and vitamin E (tocochromanol family) is a regulator of
protein kinase activity and gene expression, but their potent
antioxidant activities are arguably just as important as their
essential and non-replaceable functions. Many non-essential
compounds are known to have health-promoting antioxidant
activities, including anthocyanins, resveratrol and flavonoids. Even
metal ions, which are usually regarded as pro-oxidants, can be
important to maintain antioxidant activity in humans, because
they act as cofactors for certain antioxidant enzymes, for example
iron as a cofactor for catalase. In the industrialized world, the
fortification of processed foods with essential nutrients is taken
for granted and additional fortification with non-essential but
health promoting antioxidant compounds forms a large part of
the luxury functional foods market (Espı´n et al., 2007).
Several recent reviews have focused on the fortification of
staple foods with essential nutrients, predominantly as a strategy
to alleviate micronutrient deficiency in developing country
settings (Bai et al., 2011; Go´mez-Galera et al., 2010; Yuan et al.,
2011; Zhu et al., 2007). Here we discuss the development of
strategies for the biofortification of plants with antioxidants or
molecules that promote antioxidant activity, including essential
nutrients and nutraceuticals.
Antioxidants confer health-promoting effects
through a variety of mechanisms
Antioxidants inhibit the oxidation of other molecules and thereby
prevent them from causing oxidative damage, which is a major
contributory factor to diseases associated with ageing and with
ageing itself. Antioxidant molecules are generally either lipophilic
or hydrophilic, but both types employ common molecular
mechanisms, including hydrogen atom transfer (HAT), single-
electron transfer followed by proton transfer (SET-PT), sequential
proton loss electron transfer (SPLET) and the formation of radical
adducts (Ghanta and Chattopadhyay, 2011; Gu¨lc¸in, 2012). These
mechanisms are summarized in Figure 1. Some antioxidants have
a single active mechanism, for example ascorbate/vitamin C uses
HAT alone, whereas others employ multiple mechanisms, for
example flavonoids can use HAT, SET-PT and SPLET depending on
their molecular structure (Gu¨lc¸in, 2012).
The three major lipophilic antioxidant classes in mammals are
carotenoids, tocochromanols and coenzyme Q10, all of which
are derived from terpenoids. Carotenoids and tocochromanols
are obtained from the diet whereas coenzyme Q10 is synthesized
de novo in a multistep pathway starting with acetyl-CoA. All
three classes act primarily by scavenging lipid peroxyl radicals
(ROO˙) and by disrupting free radical chain reactions in mem-
branes. Carotenoids are tetraterpenoids (C40 isoprenoids) pro-
duced mainly by photosynthetic organisms and some fungi,
bacteria, algae and archaea, and they can be classed either as
carotenes or xanthophylls, the latter distinguished by the pres-
ence of oxygen atom(s) (Fraser and Bramley, 2004). The best
known carotenoids are those with pro-vitamin A activity (partic-
ularly b-carotene) because these represent a major dietary source
of vitamin A, but others with important antioxidant effects
include lycopene, lutein and zeaxanthin. Lycopene is the red
pigment present at high levels in tomatoes and has been shown
to reduce the risk of cardiovascular disease and some types of
cancer (Fraser and Bramley, 2004). Lutein is very abundant in
green tissue, but zeaxanthin is restricted to a few sources like
pepper and a number of corn varieties. The latter are not
particularly abundant in western diets. They are particularly
important in the macula and lens of the human eye, where they
filter high-energy blue light and counteract oxidative damage to
protect against age-related macular degeneration (Fraser and
Bramley, 2004). The tocochromanols are a group of eight
structurally related compounds collectively known as vitamin E
obtained primarily from green leaves and oilseeds. The most
potent form in humans is a-tocopherol, not because it is
intrinsically any more active than the others but because it is
absorbed most efficiently (Brigelius-Flohe and Traber, 1999).
Coenzyme Q10 is present in the mitochondria where it functions
in the electron transport chain and helps to prevent oxidative
damage to membranes. Higher levels of coenzyme Q10 may help
to prevent cardiovascular and neurological disorders as well as
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Figure 1 Mechanism of ROS generation and
detoxification in humans (Mates et al., 1999).
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certain cancers and is used as an orphan drug for the treatment
of congestive heart failure in children (Dhanasekaran and Ren,
2005).
There are many water-soluble antioxidants in mammalian diets,
ranging from simple compounds such as ascorbate to complex
molecules such as the flavonoids. The tripeptide glutathione has
an antioxidant activity which is conferred by the sulfhydryl group
of cysteine (Rennenberg, 1980). Lipoic acid uses a thiol functional
group to neutralize free radicals (Goraca et al., 2011). As well as
scavenging free radicals, hydrophilic antioxidants may also
chelate free metal ions that promote oxidation reactions. In
plants, flavonoids, phenolic acids and glutathione are responsible
for this activity, whereas uric acid and lipoic acid perform the
same function in animals (Goraca et al., 2011; Gu¨lc¸in, 2012).
However, the consumption of antioxidant phytochemicals in the
diet increases the ability of mammals to counteract oxidative
stress, reducing the frequency of cell death promoted by oxidative
damage and therefore providing benefits such as a healthy
immune system, a lower risk of disease and increased longevity
(Ghanta and Chattopadhyay, 2011).
Biofortification increases the availability of
essential nutrients and health-promoting
compounds at source
Three staple crops—rice, maize and wheat—provide 60% of the
calories consumed by humans (FAO, 2010). Milled cereals are
deficient in many nutrients, including essential amino acids
(particularly lysine), essential fatty acids, vitamins and minerals.
Human populations that subsist entirely or predominantly on
milled cereals are therefore the most at risk of deficiency diseases,
and these tend to be the rural poor in developing countries,
who are also the least likely to benefit from organized pro-
grammes to distribute fortified processed foods or vitamin and
mineral supplements (Go´mez-Galera et al., 2010; Underwood
and Smitasiri, 1999).
The limited impact of conventional interventions in developing
country settings has promoted the use of biofortification as a
sustainable approach that is equally beneficial to subsistence
farmers and consumers of processed foods (Zhu et al., 2007).
Biofortification means that nutrients and other health-promoting
compounds are incorporated while the plant is still growing, and
are therefore present in the harvested material and at all
subsequent stages en route to the consumer. Mineral biofortif-
ication can be achieved in limited cases by using mineral-rich
fertilizers although the impact of this approach depends on the
mobility of mineral ions in the soil and the ability of plants to
concentrate them in edible tissues such as cereal grains. There are
two general strategies that are suitable for biofortification with
any organic or inorganic nutrient, that is conventional breeding
and genetic engineering. These are similar in aim, albeit different
in scope. Both attempt to create plant lines carrying genes that
favour the most efficient biosynthesis and/or accumulation of
essential micronutrients and other health-promoting compounds.
Conventional breeding achieves this by crossing the best
performing plants and selecting those with favourable traits over
many generations, sometimes in combination with biotechnology
tools such as mutagenesis or marker assisted selection, whereas
genetic engineering introduces the traits as recombinant DNA
and allows the best-performing plants to be selected in a single
generation (Harjes et al., 2008; White and Broadley, 2005).
Conventional breeding is limited to genes that can be sourced
from sexually compatible plants and requires lengthy breeding
programmes to introduce traits into locally adapted elite varieties,
whereas genetic engineering has no such limitations and novel
genes can be introduced directly into local cultivars. First-
generation engineered crops with modified input traits have
already shown their potential to enhance agricultural productivity
and reduce poverty in developing countries (Christou and
Twyman, 2004; Farre´ et al., 2010a, 2011a), and now second-
generation crops that address nutritional requirements through
the direct modification of output traits are under development
(Pe´rez-Massot et al., 2012; Yuan et al., 2011). Genetic engineer-
ing also allows nutritional traits to be targeted to specific organs
(e.g. cereal seeds) and multiple traits can be combined in the
same plants without complex breeding programmes (Naqvi et al.,
2009, 2010).
Organic antioxidants, such as carotenoids, tocochromanols,
ascorbic acid and flavonoids, are synthesized de novo by plants,
so engineering strategies aiming to enhance the availability of
such compounds involve the modification of endogenous plant
metabolism (Capell and Christou, 2004). This can be achieved
using a variety of strategies as outlined in Figure 2. The most
popular strategy has been to overexpress a known rate-limiting
enzyme thus alleviating a metabolic bottleneck, preferably using
an enzyme devoid of feedback inhibition (Shewmaker et al.,
1999; Ye et al., 2000; Zhu et al., 2008). The first committed step
in a metabolic pathway is often a suitable intervention point
because this ensures flux is delivered to all downstream steps
(Enfissi et al., 2005; Morris et al., 2006). However, it is also
possible to overexpress multiple enzymes to ensure there is
adequate flux throughout the entire pathway (Ravanello et al.,
2003; Zhu et al., 2008), or express regulatory proteins to
coordinately induce an entire endogenous pathway without the
introduction of heterologous enzymes (Butelli et al., 2008; de Vos
et al., 2000). Alternative strategies to achieve the accumulation
of a specific desired metabolite include the suppression of a
competitive pathway or branch point to ensure flux is directed in
the appropriate direction (Diretto et al., 2006; Yu et al., 2008) or
the creation/enlargement of a metabolic sink, which reduces
feedback inhibition and allows the desired product to accumulate
in a stable manner (Lopez et al., 2008; Lu et al., 2006).
Different approaches must be used to achieve the accumula-
tion of minerals because these cannot be synthesized de novo
and must instead be taken up from the environment (Go´mez-
Galera et al., 2010; Zhu et al., 2007). Strategies to enhance
mineral accumulation include the introduction of genes that
improve (i) the efficiency of mineral uptake from the soil, (ii) the
efficiency of transport form the roots to storage organs, (iii) the
storage capacity and (iv) the bioavailability of the stored mineral
(Go´mez-Galera et al., 2010). These strategies are summarized in
Figure 3.
It is important to emphasize the difference between bioaccu-
mulation (the amount of a particular nutrient that can be stored
in plant tissues) and bioavailability (the amount that can be
absorbed when the plant tissue is consumed as food). Whereas
most studies have focused on bioaccumulation, the bioavailability
of nutrients in engineered crops is a more important indicator of
its nutritional quality (Hirschi, 2008). The food matrix plays an
important role in the bioavailability of organic and inorganic
compounds. For example, 12 mg of b–carotene in a food matrix
must be ingested to gain the same benefit as 1 mg of pure
b-carotene dissolved in oil. Similarly, vitamin E absorption requires
the presence of bile salts, pancreatic enzymes and oils or fats to
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promote solubility (Jeanes et al., 2004), and the bioavailability of
ascorbate is enhanced by copresentation with proteins in the
food matrix (Vinson and Bose, 1988). In the case of minerals, the
presence of antinutritional compounds such as phytate and
oxalate in vegetables can inhibit mineral absorption because they
act as chelating agents (Go´mez-Galera et al., 2010), whereas
nutritional enhancers such as inulin can promote mineral
absorption by slowing down the movement of food through
the gut (Go´mez-Galera et al., 2010). Reducing the quantities of
antinutritional compounds and/or increasing the quantities
of nutritional enhancers can therefore increase the bioavailability
of nutrients. Bioavailability may also depend on the chemical form
in which a nutrient is presented, for example selenium is absorbed
more efficiently when presented in an organic form such as
selenomethionine rather than as inorganic metal ions (Combs,
2001), and iron presented as a complex with ferritin is less
susceptible to the effects of antinutritional compounds than non-
heme iron (Lo¨nnerdal, 2009).
Transgenic flavonoid-enriched tomato intake reduced C-reac-
tive protein in human C-reactive protein transgenic mice express-
ing markers of cardiovascular risk more than in wild-type tomato
(Rein et al., 2006). Moreover, the life span of cancer-susceptible
mice fed on a diet supplemented with high-anthocyanin toma-
toes was increased substantially (Butelli et al., 2008). Recently, it
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Figure 3 Strategies for inorganic compounds:
1. Mineral uptake from the soil by specific
transporters which allow direct uptake from the
rhizosphere to the cytoplasm (Connolly et al.,
2002) and/or excretion of phytosiderophores (PS),
which bind Fe and Zn resulting in transport into
the cytoplasm (Johnson et al., 2011). 2. Efficient
transport of minerals from the roots to storage
organs-nicotianamine (NA), mineral-citrate or
mineral-deoxymugineic acid (DMA) complexes
(Ishimaru et al., 2010). 3. Storage of minerals in
the edible part of the plant in a form that is
available in the diet and non-toxic to the plant; for
example, ferritin specifically binds Fe and Zn
(Drakakaki et al., 2005) and selenocysteine is a
sink for Se (Ellis et al., 2004). 4. Increase the
amount of bioavailable minerals accumulated in
plants by degradation of phytic acid through
phytase and then make Fe, Zn and Se available for
absorption in the human gut (Drakakaki et al.,
2005) and/or use of compounds known to
promote mineral absorption such as inulin,
b-carotene or ascorbic acid (White and Broadley,
2005).
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Figure 2 Strategies to modulate organic
compound levels in plants. These strategies
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precursors to increase flux through the pathway
by overexpressing the enzyme that catalyses the
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has been demonstrated that b-carotene in biofortified rice
(Golden Rice) and maize has good bioavailability as a plant
source of vitamin A in humans (Li et al., 2010; Muzhingi et al.,
2011; Tang et al., 2009). Toxicity assessment in mice fed with
multivitamin maize showed no adverse health effects and did not
induce any clinical sign of toxicity (Arjo´ et al., 2012).
Genetic engineering for biofortification with
lipophilic antioxidants
Carotenoids
The carotenoid biosynthesis pathway in plants (and equivalent
bacterial enzymes) is shown in Figure 4a. The key aspects of the
pathway in the context of metabolic engineering are that the first
committed step is catalysed by the enzyme phytoene synthase
(PSY/CRTB) and that the next four desaturation and isomerization
steps which produce all-trans lycopene are carried out by four
enzymes in plants but by a single bacterial enzyme known as CRTI
(phytoene desaturase), which is therefore preferred for genetic
engineering to reduce the number of transgenes required.
Lycopene represents a branch point in the pathway, where the
competing activities of beta and epsilon cyclases (LYCB/CRTY and
LYCE) result in the production of b-carotene (pro-vitamin A) and
a-carotene. These products are then converted into lutein and
zeaxanthin, respectively, by the activity of carotene hydroxylases.
As discussed above, there are multiple strategies available to
enhance carotenoid production and one popular approach has
been the overexpression of PSY/CRTB to alleviate the metabolic
bottleneck at the first committed step in the pathway. One
successful example of this approach in canola resulted in a
50-fold increase in carotenoid levels in the seeds (to 1617 lg/g
fresh weight, FW), predominantly represented by a-carotene and
b-carotene (394 and 949 lg/g FW, respectively), and was
achieved by expressing the CRTB gene under the control of a
seed-specific promoter (Shewmaker et al., 1999). The engineered
canola was the pioneering work for the successful enhancement
of carotenoid production in crop plants. The success of this
approach relied on the fact that enzymes acting downstream of
PSY were not limiting in canola seeds and the phytoene was
successfully converted into downstream carotenoids.
However, the expression of daffodil PSY in rice endosperm only
resulted in the accumulation of phytoene because the subsequent
desaturation steps were also limiting (Burkhardt et al., 1997;
Schaub et al., 2005). This is in contrast to canola which contains a
native carotenogenic pathway. Therefore, to boost carotenoid
levels in rice grains, it was necessary to express multiple enzymes
from the pathway. Initially, daffodil PSY was combined with the
multifunctional bacterial enzyme CRTI resulting in the accumu-
lation of b-carotene and xanthophylls in ‘Golden Rice’ (Ye et al.,
2000). These results indicated that the endogenous levels of
lycopene cyclases and carotene hydroxylases were sufficient to
convert the lycopene generated by CRTI into downstream
products (Schaub et al., 2005). Later, the amount of b-carotene
was increased to 31 lg/g dry weight (DW), a 17-fold improve-
ment, by replacing the daffodil PSY with its more efficient corn
ortholog, resulting in the higher performance Golden Rice II
(Paine et al., 2005). Tissue-specific transgene expression is critical
for successful carotenoid modulation. For example, the first
report of tomato engineered to expressed tomato PSY1 consti-
tutively resulted in a dwarft phenotype due to the depletion of
the endogenous precursor pool of geranylgeranyl diphosphate
(GGPP) leading to a shortage of gibberellins (Fray et al., 1995).
This was overcome subsequently by fruit-specific expression of
bacterial CRTB (Fraser et al., 2002). Flux through the carotenoid
pathway can also be increased by making more precursors
available by engineering upstream pathways [e.g. by overex-
pressing 1-deoxy-D-xylulose 5-phosphate (DXP) synthase (DXS) to
provide more DXP in the methylerythritol phosphate (MEP)
pathway; Enfissi et al., 2005] but this also increases flux through
unrelated pathways that utilize the same precursors, so is less
efficient and targeted.
Whereas the results described above appear to reflect the
additive effects of transgenic and endogenous metabolic capabil-
ities, more complex interactions have been observed when
feedback effects occur between the superimposed pathways.
The expression of CRTI in tomato was envisaged to enhance the
lycopene content but actually resulted in a threefold increase in b-
carotene levels while reducing the overall level of carotenoids
including lycopene (Ro¨mer et al., 2000). The elevated b-carotene
content was unexpected because of the low LYCB levels normally
found in tomato fruits, but further investigation revealed that the
endogenous LYCB gene had been induced in the transgenic plants
(Ro¨mer et al., 2000). The outcome of the above strategy therefore
depends on the relative activities of endogenous LYCB and LYCE
which vary in different plants and even in different cultivars, so
more predictable results can be achieved by deliberately express-
ing one or other of the enzymes to increase flux in the appropriate
direction beyond the branch point. As an example, the overex-
pression of LYCB in tomato fruits increased the accumulation of
b-carotene and zeaxanthin at the expense of a-carotene and
lutein (D’Ambrosio et al., 2004; Rosati et al., 2000). Similarly,
transgenic canola seeds expressing CRTB, CRTI and CRTY
accumulated more carotenoids than wild-type seeds and the
b:a-carotene ratio increased from 2:1 to 3:1, showing that the
additional lycopene b-cyclase (CRTY) activity skewed the compe-
tition for the common precursor lycopene and increased flux
specifically towards b-carotene (Ravanello et al., 2003). In corn,
the outcome of such experiments depends on competition and
complementarity between the transgenic and endogenous path-
ways. For example, in the white inbred M37W which lacks
significant amounts of carotenoids in the endosperm, the expres-
sion of PSY, CRTI and LYCB increased the b:a–carotene ratio from
1.21 to 3.51 (Zhu et al., 2008) and zeaxanthin levels were
29.64 lg/g DW, but also enhanced flux through the competing
branch, resulting in nearly 25-fold the normal levels of lutein (up to
10.76 lg/g DW) showing that LYCE activity is not a limiting step in
corn endosperm. In contrast, the introgression of the same
pathway into two yellow-endosperm varieties with opposing
b:a–carotene ratios (0.61 for EP42 and 1.90 for A632) generated
one hybrid accumulating lutein (23.41 lg/g DW) with a
b:a–carotene ratio of 2.05 and the other accumulating high levels
of zeaxanthin (56.9 lg/g DW) with a b:a–carotene ratio of 6.8
(Naqvi et al., 2011a).
Carotenoid profiles can also be modulated by inhibiting
endogenous carotenogenic enzymes, for example by a tuber-
specific antisense approach against LYCE in potato which
increased b-carotene levels by up to 14-fold and total carotenoid
levels by up to 2.5-fold. However, there was no corresponding
reduction in lutein levels again suggesting that LYCE is not a rate-
limiting step (Diretto et al., 2006). Similar results were observed
in canola seeds by RNA interference against LYCE (Yu et al.,
2008). The inhibition of b-carotene hydroxylase (BCH) prevents
b-carotene from being converted into zeaxanthin, and this
strategy has achieved 38-fold increase in b-carotene levels in
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(a)
Figure 4 (a) Carotenoid biosynthetic pathway in plants and equivalent steps in bacteria (Farre´ et al., 2010b, 2011b). Abbreviations: CRTB, bacterial
phytoene synthase; CRTI, bacterial phytoene desaturase; CRTISO, carotenoid isomerase; CRTY, bacterial lycopene b-cyclase; CRTZ, bacterial b-carotene
hydroxylase; CYP97C, heme-containing cytochrome P450 carotene e-ring hydroxylase; DMAPP, dimethylallyl diphosphate; DXP, 1-deoxy-D-xylulose
5-phosphate; DXR, DXP reductoisomerase; DXS, DXP synthase; GA3P, glyceraldehyde 3-phosphate; GGPP, geranylgeranyl diphosphate; GGPPS, GGPP
synthase; HDR, HMBPP reductase; HMBPP, hydroxymethylbutenyl 4-diphosphate; HYDB, b-carotene hydroxylase [non-heme di-iron b-carotene hydroxylase
(BCH) and heme-containing cytochrome P450 b-ring hydroxyalses (CYP97A and CYP97B)]; IPP, isopentenyl diphosphate; IPPI, isopentenyl diphosphate
isomerase; LYCB, lycopene b-cyclase; LYCE, lycopene e-cyclase; MEP, methylerythritol 4-phosphate; PDS, phytoene desaturase; PSY, phytoene synthase;
VDE, violaxanthin de-epoxidase; ZDS, f-carotene desaturase; ZEP, zeaxanthin epoxidase; Z-ISO, f-carotene isomerase. (b) Vitamin E biosynthesis in plants
(Farre´ et al., 2012a). Tocochromanols are synthesized on the inner chloroplast membrane from precursors derived from the shikimate and MEP pathways.
The shikimate pathway contributes the head-group precursor homogentisic acid (HGA), whereas the MEP pathway gives rise to the side-chain precursors
phytyldiphosphate (PDP) and geranylgeranyldiphosphate (GGDP). The first committed step in the reaction is the cytosolic conversion of
q-hydroxyphenylpyruvic acid (HPP) to HGA by q–hydroxyphenylpyruvic acid dioxygenase (HPPD). HGA is then prenylated with either PDP or GGDP to
produce the intermediates 2-methyl-6-phytyl benzoquinone (MPBQ) and 2-methyl-6-geranylgeranylplastoquinol (MGGBQ). A second methyl group is
added by MPBQ methyltransferase (MPBQ-MT) in the tocopherol branch and MGGBQ methyltransferase (MGGBQ-MT) in the tocotrienol branch, producing
the intermediates 3-dimethyl-5-phytyl-1,4-benzoquinone (DMPBQ) and 2-dimethyl-6-geranylgeranylbenzoquinol (DMGGBQ). All four of these interme-
diates are substrates for tocopherol cyclase (TC), which produces d and c tocopherols and tocotrienols. Finally, c-tocopherol methyltransferase (c-TMT)
catalyses a second ring methylation to yield a and b tocopherols and tocotrienols. Other abbreviations: GGDR, geranylgeranyl diphosphate reductase;
HGGT; homogentisate geranylgeranyl transferase; HPT, homogentisate phytyltransferase. (c) Postulated ascorbate biosynthesis and recycling pathways
(Ishikawa and Shigeoka, 2008; Ishikawa et al., 2006). Abbreviations: AO, ascorbate oxidase; APX, ascorbate peroxidase; DHAR, dehydroascorbate
reductase; GalLDH, L-galactono-1,4-lactone dehydrogenase; GalUR, D-galacturonate reductase; GDH, L-galactose dehydrogenase; GGP, GDP-L-galactose
phosphorylase; GlOase, L-gulonolactone oxidase; GME, GDP-mannose-3′,5′ epimerase; GMP, GDP-mannose pyrophosphorylase; GPP, L-galactose
1-phosphate phosphatase; MDHAR, monodehydroascorbate reductase; Miox, myo-inositol oxidase.
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potatoes, in concert with a 3.7-fold increase in lutein levels and a
0.5 fold reduction in zeaxanthin levels (Diretto et al., 2007).
Targeting the next step in the pathway (zeaxanthin epoxidase,
ZEP) prevents zeaxanthin from being converted into downstream
products, and this strategy increased total carotenoid levels 5.7-
fold, b-carotene levels 3.4-fold, lutein levels 1.9-fold and
zeaxanthin levels 133-fold (Ro¨mer et al., 2002). Vitamin E (a–
tocopherol) was increased two to threefold in the transgenic
potatoes. Fine-tuning these alterations has the potential to
significantly enhance the nutritional value of potatoes. These
studies show that carotenoid levels in plants can be increased
both by alleviating early bottlenecks and introducing bottlenecks
at later steps or in competitive branches.
A final strategy that has been used to enhance b-carotene and
total carotenoid levels in plants is to increase the number of
storage compartments (Lopez et al., 2008; Lu et al., 2006).
Carotenoids are stored in adapted plastids, so increasing the
number of these organelles or encouraging their differentiation
can act as a metabolic sink, shifting the metabolic equilibrium
towards carotenoid synthesis. The cauliflower Or gene was
identified through the discovery of a dominant allele that causes
the curd to become orange, and the overexpression of this allele
in potato under the control of the granule-bound starch synthase
(GBSS) promoter produced potato tubers with bright orange flesh
and carotenoid levels of up to 31 lg/g DW, including 3.75 lg/g
DW b-carotene (Lopez et al., 2008).
(b)
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Figure 4 (Continued)
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In some of the examples discussed above, the introduction of
heterologous enzymes has enhanced the production of carote-
noids that are already produced in moderate to large amounts or
has modified the carotenoid profile of edible plant tissues,
whereas in other cases the endogenous tissues do not produce
carotenoids and the entire pathway must be introduced de novo
(e.g. Golden Rice). Similarly, most plants do not produce
ketocarotenoids such as astaxanthin and canthaxanthin, which
are the pink/red pigments most frequently found in seafood and
have potent, health-promoting antioxidant activities (Zhu et al.,
2009). Ketocarotenoids are currently produced in bacteria and
are added artificially to fish feed pellets to increase the pigmen-
tation of for example farmed salmon and trout. The expression of
bacterial b-carotene ketolases in corn endosperm has resulted in
the production of astaxanthin corn lines that could be valuable
sources of ketocarotenoids in the aquaculture, nutraceutical and
cosmetic industries (Zhu et al., 2008).
Tocochromanols
The tocochromanol biosynthesis pathway in plants is shown in
Figure 4b. The key aspects of this pathway in the context of
metabolic engineering are that it begins with the prenylation of
homogentisic acid (HGA), derived from the shikimate pathway,
with phytyldiphosphate (PDP), derived from the MEP pathway,
and that prenylation may be carried out by two different enzymes
—homogentisate phytyltransferase (HPT) or homogentisate ger-
anylgeranyl transferase (HGGT)—to generate alternative interme-
diates that give rise to the tocopherol and tocotrienol branches of
the pathway, respectively. These intermediates are substrates for
the same three enzymes, yielding eight different products, so
genetic engineering can be used not only to increase the total
tocochromanol content, but also to alter the relative levels of the
different forms. This provides a strategy to boost levels of the
most potent form, a-tocopherol (Farre´ et al., 2012a).
As with carotenoid engineering, total tocochromanol levels in
plants can be increased by expressing single or multiple rate-
limiting enzymes. HGA is the key target because it is the last
common precursor before the pathway splits into multiple
branches, and HGA levels can be boosted by expressing enzymes
in the shikimate pathway such as TyrA and/or HPPD which
increase total tocochromanol levels without significantly affecting
the balance between different forms (Karunananda et al., 2005).
In contrast, the expression of downstream enzymes such as
MPBQ-MT and c-tocopherol methyltransferase (c-TMT) has the
effect of interconverting different forms of vitamin E without a
significant impact on total tocochromanol levels. For example, the
expression of MPBQ-MT (VTE3) in Arabidopsis seeds increased the
total tocopherol content marginally but caused the preferential
accumulation of c-tocopherol (75%–85% of total tocopherols;
Van Eenennaam et al., 2003). Similarly, the expression of c-TMT
had no impact on total tocochromanol levels but resulted in 85%
–95% of the total tocopherol pool being converted into
a–tocopherol, representing an 80-fold increase over wild-type
seeds and a ninefold increase in total vitamin E activity indicating
that flux was diverted into the a-branch of the pathway (Shintani
and DellaPenna, 1998). Transgenic soybeans expressing MPBQ-
MT and c-TMT accumulated >95% a-tocopherol, resulting in a
greater than eightfold increase of a-tocopherol and an up to
fivefold increase in seed vitamin E activity (Van Eenennaam et al.,
2003). The result was a fivefold increase in vitamin E activity.
Similar increases in vitamin E activity were achieved following
the overexpression of c-TMT in lettuce (Cho et al., 2005), but the
most promising results were achieved by crossing transgenic
lettuce lines expressing HPT (thus a higher flux through the entire
pathway) with those expressing c-TMT (skewing the pathway in
favour of a-tocopherol). This resulted in an increase of both the
total tocopherol content and the a/c tocopherol ratio (Cho et al.,
2005). More recently, lettuce plants simultaneously transformed
with the Arabidopsis genes encoding HPT and c-TMT also showed
both quantitative and qualitative increases in vitamin E activity,
a sixfold increase in the total tocopherol content and also a sixfold
increase in the a/c ratio (Li et al., 2011).
The overexpression of HGGT should favour the tocotrienol
branch of the pathway, but corn seeds overexpressing HGGT
accumulated six times the normal levels of both tocotrienols and
tocopherols (Cahoon et al., 2003). Recently, rice seeds expressing
Arabidopsis HPPD resulted in a small increase in absolute
tocotrienol synthesis (but no change in the relative abundance
of the c and a isoforms). In contrast, there was no change in the
absolute tocopherol level, but a significant shift from the a to the
c isoform. These data confirm that HPPD is not rate limiting, and
that increasing flux through the early pathway reveals down-
stream bottlenecks that act as metabolic tipping points (Farre´
et al., 2012b). The combined expression of HPPD and MPBQ-MT
resulted in a threefold increase in c-tocopherol levels without
changing the total tocopherol content (Naqvi et al., 2011b).
These experiments again showed that flux was directed into the
a-branch but in this case it was blocked by low c–TMT activity,
forcing the accumulation of c–tocopherol (Naqvi et al., 2011b).
Coenzyme Q10
The metabolic engineering of fat-soluble antioxidants has under-
standably focused on carotenoids and tocochromanols because
of their status as essential nutrients. However, the beneficial
properties of coenzyme Q10 have prompted investigations into
good dietary sources of this compound and the development of
strategies to increase its abundance by genetic engineering,
potentially to provide additional sources for the nutraceutical
industry. The most significant studies involved the expression of
the Gluconobacter suboxydans decaprenyl diphosphate synthase
gene in rice, with the corresponding enzyme targeted for import
into the mitochondria which is the normal site of coenzyme Q10
activity in humans and the site of coenzyme Q9 synthesis in wild-
type rice (Takahashi et al., 2006, 2009, 2010). This approach was
chosen because it allowed the production of coenzyme Q10
through the extension of an existing metabolic pathway using a
single enzyme, and because coenzyme Q10 is preferentially
localized in the bran and germ suggesting that the ingestion of
coenzyme Q10 could be increased by the consumption of
unmilled brown rice as a health food (Takahashi et al., 2010).
Genetic engineering for fortification with
hydrophilic antioxidants
Ascorbate
Unlike carotenoids and tocochromanols, which are synthesized
de novo in plants through a unique pathway, a key aspect of
ascorbate biosynthesis in the context of metabolic engineering is
that it may be synthesized de novo via several pathways or
recycled from oxidation products, offering multiple intervention
points for nutritional enhancement (Ishikawa et al., 2006). An
overview of ascorbate synthesis and recycling is shown in
Figure 4c. The major de novo synthesis pathway involves the
intermediate L–galactose (Wheeler et al., 1998) but alternative
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routes via L-gulose (Wolucka and Van Montagu, 2003),
D–galacturonic acid (Agius et al., 2003) and myo-inositol (Lorence
et al., 2004) have been identified in particular species and tissues.
As discussed earlier, one of the key intervention methods is to
overexpress a rate-limiting enzyme, and in the L-galactose
pathway this has been achieved by targeting GDP-L-galactose
phosphorylase (GGP), resulting in increases of between two and
sixfold in crops such as tomato, potato and strawberry (Bulley
et al., 2012). The first committed step in the L–galactose pathway
is catalysed by GDP-mannose-3′,5′-epimerase, and transgenic
tomato plants expressing two isoforms of this enzyme showed a
modest 1.6-fold increase in ascorbate levels in ripe tomato fruits
(Zhang et al., 2011). Success has also been achieved by targeting
the alternative biosynthesis pathways, for example the rate-
limiting L-gulonolactone oxidase in the myo-inositol pathway
which resulted in a sevenfold increase in ascorbate in lettuce,
although only a 1.4-fold increase in potato (Hemavathi et al.,
2010; Jain and Nessler, 2000).
The ascorbate recycling pathway has been utilized for meta-
bolic engineering in corn (Chen et al., 2003; Naqvi et al., 2009),
potato (Goo et al., 2008) and tomato (Haroldsen et al., 2011) by
overexpressing the key enzyme dehydroascorbate reductase
(DHAR). Ascorbate levels in corn endosperm increased twofold
following the constitutive overexpression of wheat DHAR (Chen
et al., 2003) but sixfold following endosperm-specific expression
of rice DHAR (Naqvi et al., 2009). A 1.6-fold increase in ascorbate
was achieved in ripe tomato fruits constitutively expressing
tomato DHAR (Haroldsen et al., 2011). Potato tubers constitu-
tively expressing a sesame DHAR enzyme showed a 1.6-fold
increase in ascorbate, while the use of a tuber-specific promoter
resulted in a marginally lower 1.3-fold increase (Goo et al., 2008).
It therefore appears that ascorbate metabolic engineering is
exquisitely sensitive to the source of the heterologous enzyme
and its spatiotemporal expression profile in the transgenic plants,
which is likely to reflect the complex regulatory systems to control
ascorbate accumulation.
Flavonoids
Flavonoids, a large structurally diverse class of more than 9000
polyphenolic compounds, are synthesized via the phenylpropa-
noid pathway by plants and microbes. They include chalcones,
flavones, flavonols, flavanones, anthocyanins and isoflavonoids
(Wang et al., 2011). Although the phenylpropanoid pathway is
complex and incompletely understood, key rate-limiting enzymes
have been identified allowing the use of metabolic engineering to
increase the overall flavonoid content, and the levels of particular
subclasses (Wang et al., 2011).
Flavonoid metabolic engineering has highlighted two strategies
for the production of antioxidant compounds. The first is the
introduction of different structural genes from diverse plants to
create a recombinant biosynthesis pathway. For example, genes
encoding stilbene synthase, chalcone synthase, chalcone reduc-
tase, chalcone isomerase and flavone synthase from different
sources were combined in transgenic tomatoes, resulting in the
accumulation of stilbenes (resveratrol and piceid), deoxychalcones
(butein and isoliquiritigenin), flavones (luteolin-7-glucoside and
luteolin aglycon) and flavonols (quercetin glycosides and kaempf-
erol glycosides) in the fruit peel (Schijlen et al., 2006). The total
antioxidant capacity of the transgenic fruit peel was more than
three times higher than wild-type fruits. These experiments show
that genetic engineering can not only increase the levels of
potentially health-promoting antioxidant compounds in fruits, but
can also provide insight into the underlying metabolic pathways
and allow the selection of particular flavonoid compounds.
The second approach involves the combinatorial use of
different regulatory factors to increase flavonoid levels. For
example, tomato fruits produce only low amounts of flavonols
such as kaempferol and quercetin, which are concentrated in the
fruit peel. However, the expression of corn regulatory genes Lc
and C1 induced the production of kaempferol in the fruit flesh,
increasing overall levels by 60% (de Vos et al., 2000). The
additional expression of chalcone isomerase increased the flavo-
nol concentration in the fruit peel by 78-fold, mainly due to the
accumulation of rutin (Muir et al., 2001). Corn regulatory genes
(this time C1 and R) have also been expressed in soybean,
resulting in a twofold increase in isoflavonoids levels. The
expression of these genes in conjunction with cosuppression of
flavanone 3 hydroxylase (F3H) to block the anthocyanin and
flavonol pathways resulted in a fourfold increase in the isoflavone
content (Yu et al., 2003). Finally, tomato plants expressing two
snapdragon-derived transcription factors accumulated anthocya-
nins at levels comparable to those found in blackberries and
blueberries, which are among the best sources of dietary
anthocyanins although they are more expensive and are con-
sumed in smaller quantities than tomatoes (Butelli et al., 2008).
The hydrophilic antioxidant capacity of the tomato fruits was
threefold higher than wild type fruits, and the peel and flesh were
both intense purple in coloration.
Melatonin
Melatonin is known as a terminal antioxidant because it forms
stable oxidation products that cannot be recycled. It is synthesized
de novo in humans and has a major role in the regulation of
circadian rhythms, but it is also produced by plants where it fulfils
an analogous role in the regulation of photoperiod responses as
well as acting as an antioxidant. Melatonin is used as a drug to
treat certain circadian disorders such as delayed sleep phase
syndrome and seasonal affective disorder, but its antioxidant
properties are also relevant as it has been indicated for protection
against radiation and can also reduce the risk of certain forms of
cancer. Melatonin is also sold as a dietary supplement in the USA.
The biosynthesis of melatonin in plants is incompletely under-
stood, but several enzymes in the pathway have been expressed
in transgenic plants including arylalkylamine N-acetyltransferase
(AANAT), N-acetylserotonin O-methyltransferase (ASMT) and 2,3-
dioxygenase (IDO) (Okazaki et al., 2009, 2010). For example, an
algal AANAT enzyme has been expressed in Micro-Tom tomato
(Okazaki et al., 2009) and human AANAT has been expressed in
rice (Kang et al., 2010), in both cases leading to elevated
melatonin levels in the transgenic plants. In contrast, melatonin
levels decreased in transgenic rice plants expressing IDO, poten-
tially reflecting the induction of a feedback mechanism (Okazaki
et al., 2010). Because melatonin is a natural bioregulator in
plants, its synthesis can also be induced by the application of
exogenous chemicals such as benzothiadiazole (BTH) and chito-
san (CHT) (Vitalini et al., 2011). Interestingly, it has been shown
that plants with higher levels of melatonin have a normal level of
b-carotenoids, but double the normal amount of vitamin E, and
significantly higher quantities of vitamin C and glutathione,
suggesting that part of the defense pathway induced by
melatonin includes the induction of additional antioxidants
(Wang et al., 2012).
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Antioxidant activity can depend on the
abundance of metal ions
A number of metals are required by humans in small amounts
because they act as cofactors for enzymes, transcription factors
and signalling proteins. This includes several enzymes whose
function is to detoxify reactive oxygen species, which means
metal ions are required as cofactors for antioxidant enzymes,
including different forms of superoxide dismutase (requiring Cu,
Mn and/or Zn; Johnson and Giulivi, 2005), catalase (requiring Fe)
and glutathione peroxidase (requiring Se) (Mates et al., 1999).
This presents an interesting quandary because metal ions are also
responsible for oxidation reactions and the body has numerous
mechanisms to sequester and/or compartmentalize metals to
ensure they do not cause oxidative damage. A key example is
iron, which generates hydroxyl radicals through the Fenton
reaction, a process which is facilitated by metal ion reduction
mediated by ascorbate. Iron is therefore both necessary and
potentially toxic, which means it must be stored and transported
in a bioavailable but inactive form using proteins such as
transferrin and ferritin (Crichton and Charloteaux-Wauters,
1987; Theil, 1987).
The biofortification of crops with metals is nutritionally relevant
because iron and zinc deficiencies are prevalent in developing
countries, but selenium is also an important target for biofortif-
ication particularly in regions with selenium-depleted soils. The
strategies used for mineral biofortification depend on the mobility
of the metal in the soil and its metabolism by the plant. For
example, iron tends to be immobilized by interactions with soil
particles (particularly in alkaline soils) so biofortification strategies
must increase its mobility as well as its transport and storage (Lee
et al., 2012), whereas zinc is highly mobile in the soil and
biofortification strategies focus on transport and storage alone
(Palmgren et al., 2008; Stomph et al., 2009). Selenium is unusual
because it can be incorporated into organic compounds in place
of sulphur, such compounds being essential in humans but
metabolic byproducts in plants.
Plants take up minerals from the soil in two different ways, one
involving the direct absorption of mobile ions through specific
transporters in the root plasma membrane, and the other
involving the synthesis and secretion of chelating agents known
as phytosiderophores which mobilize metals that have adsorbed
onto soil particles, particularly iron. Genetic engineering can be
used to enhance both mechanisms for example by overexpressing
transporters to increase the uptake capacity of roots (Connolly
et al., 2002; Grotz et al., 1998; Terry et al., 2000) and by
expressing enzymes in the phytosiderophore biosynthesis path-
way such as nitotianamine synthase (NAS; Johnson et al., 2011)
or nicotianamine aminotransferase (NAAT; Takahashi et al.,
2001) to increase the mobilization of metal ions in the soil.
However, because such proteins are often promiscuous, these
strategies often lead to the coaccumulation of iron and zinc. For
example, the overexpression of rice NAS in transgenic rice plants
under the control of a seed-specific promoter resulted in the
accumulation of up to 19 lg/g DW of Fe and 52–76 lg/g DW of
Zn in rice grains (Johnson et al., 2011). In cassava, the expression
of the algal iron-transport protein FEA1 increased the level of Fe
fourfold to 40 lg/g DW in transgenic tubers whereas the
expression of Arabidopsis zinc transporters AtZAT1 and AtZIP1
increased the zinc content by up to fourfold and 10-fold,
respectively (Sayre et al., 2011).
After absorption by the roots, metals are transported to sink
tissues such as fruits or seeds through the phloem, so the
overexpression of phloem plasma membrane transporters (YSL
family transporters) can play an important role in biofortification
(Ishimaru et al., 2010). Once they reach the sink tissues, metals
must be stored in a bioavailable form if they are to be useful for
nutritional purposes. This can be achieved by expressing metal
storage proteins such as ferritin, which store both Fe and Zn
(Drakakaki et al., 2005; Wirth et al., 2009) or enzymes such as
selenocysteine methyltransferase (Ellis et al., 2004), which con-
verts inorganic Se into an organic form. The overexpression of
phytase, a fungal enzyme which degrades phytic acid, is a useful
strategy to increase mineral bioavailability in rice (Wirth et al.,
2009) and corn (Drakakaki et al., 2005) because this prevents
phytic acid in the gut chelating metal ions and preventing
absorption.
Conclusions and perspectives
Antioxidants are interesting targets for biofortification because
they encompass essential nutrients for vulnerable populations in
many developing countries as well as non-essential nutraceutical
compounds which are presented as food additives or functional
foods for the luxury markets in the West. Notwithstanding these
differences, many of the same technical issues must be addressed
in both environments, that is the need to modulate endogenous
plant metabolic pathways to ensure that flux is directed to the
appropriate compounds, the need to ensure such compounds
accumulate in the most appropriate tissues and the focus on
bioavailability rather than bioaccumulation. The examples dis-
cussed above provide a snapshot of the diverse approaches to
antioxidant biofortification which are driven by the nature of the
endogenous metabolic pathways. Where there is a single, well-
characterized pathway (e.g. carotenoids and tocochromanols) it is
often appropriate to target individual rate-limiting steps or key
branch points, often through a combination of interventions to
relieve early bottlenecks and reduce metabolic loss through
downstream catabolism. In these cases, it is possible to affect the
pathway either quantitatively (by targeting early, common steps)
or qualitatively (by targeting branch points) to generate novel
profiles of compounds. Where multiple pathways are present
(e.g. ascorbate), there is also a tendency towards complex
regulation that favours homeostasis. In these cases, it is often
more productive to focus metabolic interventions in a localized
manner (e.g. in seeds) to avoid feedback that can occur when
transgenes are expressed constitutively. In contrast, the highly
complex and multiple branched flavonoid pathway provides an
example where targeting the regulatory genes is more beneficial.
In the future, it is likely that genetic engineering will be used to
modify different pathways simultaneously, as recently demon-
strated by the production of multivitamin corn with elevated
levels of three vitamins (b-carotene, ascorbate and folic acid) but
also other carotenoids, providing higher levels of several key
antioxidants (Naqvi et al., 2009). As such ventures become more
ambitious, it is likely that the complex interactions between
pathways will become more apparent, meaning that interven-
tions will need to become more refined and focused to avoid
conflicts such as competition for substrates, precursors and
intermediates (Zhu et al., 2007). It is therefore clear that as well
as looking at the structural genes that represent each metabolic
pathway, we also need to consider the regulatory factors, the
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interplay between metabolic flux and enzyme activity, the
compartmentalization of different enzymes and the shuttling of
intermediates, the interplay between endogenous and heter-
ologous pathways in transgenic plants and the impact of
metabolic interventions at the level of the metabolome.
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